HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3Jerzy‐Roch Nofer, Bodo Levkau, Markus van der Giet et al.|Journal of Clinical Investigation|2004Cited by 620
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3Jerzy–Roch Nofer, Bodo Levkau, Markus van der Giet et al.|Journal of Clinical Investigation|2004Cited by 598
High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P <sub>3</sub> Lysophospholipid ReceptorGregor Theilmeier, Bodo Levkau, Christoph Schmidt et al.|Circulation|2006Cited by 413
Immunomodulator FTY720 Induces eNOS-Dependent Arterial Vasodilatation via the Lysophospholipid Receptor S1P <sub>3</sub>Markus Tölle, Markus van der Giet, Petra Keul et al.|Circulation Research|2005Cited by 123
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, David Kremer, Christopher Nelke et al.|Journal of Neurology Neurosurgery & Psychiatry|2022Cited by 30